The internal environment of a tumour can be very different from the rest of the bo...
Glioblastoma patients have poor survival rates, partly due to the cancer’s unique abi...
Twelve years ago, Dr Perret packed her bags for Europe, having recently completed her...
David, who was diagnosed with non-Hodgkin lymphoma in 2017, ultimately travelled to B...
In its latest round of funding, Te Pūtea Rangahau a Marsden, the Marsden Fund, has al...
New Zealand’s first clinical trial of CAR T-cell therapy, a revolutionary new approac...
Recently published in the journal Redox Biology, the research team found that prior t...
The Ministry of Business, Innovation and Employment’s Partnership Scheme will contrib...
Director of the Malaghan Institute of Medical Research Professor Graham Le Gros says...
The decision to award a Nobel Prize to two leading immunotherapy researchers is well ...